FREE DAILY STOCK MARKET NEWS

You have Successfully Subscribed!

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

FREE DAILY STOCK MARKET NEWS

You have Successfully Subscribed!

For up to date market news follow us
on our live twitter feed @TheMarketBullAU

  • Home
  • Market Sector
    • Mining
    • Energy
    • Health
  • Videos
  • Newsletters
  • Contact Us
  • Upload Audio
  • About Us
  • Home
  • Market Sector
    • Mining
    • Energy
    • Health
  • Videos
  • Newsletters
  • Contact Us
  • Upload Audio
  • About Us

LGP pivots harder for Euro cannabis market

19 May 2022

ASX: LGP

Health
Jack Baker

Little Green Pharma has struck a $7.5 million take-or-pay deal with Four 20 Pharma, introducing its new high-THC cannabis strain into Germany.

The company’s largest single-strain off-take contract comes on the heels of its recent $9m offtake with vertically integrated producer Demecan.

Under the agreement, Four 20 will purchase $7.5m of product over 30 months representing a ‘revolutionary step’ in LGP’s supply processes and contract portfolio entering the German market predicted to be worth EUR 9.08 billion by 2028.

The company said its new partner held a highly successful track record of supplying products to the European market.

“Another significant milestone in LGP’s continued growth of its Danish Facility and an exciting development in supply processes that promises to shorten supply timelines for future key strains dramatically,” chief executive Fleta Solomon said.

The company remain focused on increasing sales while carrying on education and research into the sector.

First product deliveries are expected late next quarter or early in the new financial year.

Material Terms of Agreement

  • Term is 2.5 years, with a minimum annual purchase commitment of $3.5 million per year following a 6-month ramp-up
  • Fixed price indexed to Danish CPI
  • Take-or-pay commitment requires Four 20 Pharma to purchase minimum quarterly quantities each quarter of white-label bulk SMS strain or pay liquidated damages equal to the purchase price if make-up quantities are not purchased in the subsequent quarter
  • Agreement subject to the following conditions precedent: sufficient data to support a shelf life of at least 6 months, entry into GMP Quality Agreement, and the grant of approvals to supply the strain into Germany, which conditions precedent must be satisfied within 6 months of Agreement execution
  • Supply of the product is exclusive to Four 20 Pharma in Germany
  • Agreement includes payment of development fee to help defray the cost of strain development, in equal tranches after completion of stability testing and first product supply

LGP’s Australian Stock Exchange-listed share price has risen 4.62 per cent today, selling at 34c (9.42 am UTC+ 8 hours).

Prominence Energy Logo

LATEST VIDEOS

Little Green Pharma (ASX: LGP) fertile for vertical growth in opening international markets 
Little Green Pharma (ASX: LGP) fertile for vertical growth in opening international markets 

MORE NEWS

  • LGP bloom brighter in Europe
  • Cannabis and marijuana legalization concept. Symbol of cannabis leaf on green traffic light. 3d illustrationLittle Green Pharma blooms in Germany

COMPANY OVERVIEW

Little Green Pharma, together with its exclusive manufacturing and distribution partners, holds all the necessary licenses and permits to operate and is a vertically integrated medicinal cannabis company. The company is a differentiated player in the rapidly expanding medical cannabis market and is driven by a strong belief that everybody deserves good health.

COMPANY INFORMATION

ASX: LGP

Website
littlegreenpharma.com

Company Announcements & Stock Information
Click here

FREE DAILY STOCK
MARKET NEWS

Thank you! You are now subscribe to receive our newsletter.

Subscribe

About The Market Bull

The Market Bull (TMB) is a leading media group providing daily market news throughout the world. Communication by TMB allows listed companies and investors to be well informed of emerging developments.

ACN: 648 544 174
AFSL: 485946

Sales Enquiries

hayley@themarketbull.com.au

Level 45, 108 St Georges Terrace, Perth, WA, 6000

Remuneration /
Income disclosure

The Market Bull or related entities may receive, or be entitled to receive financial payments or equity in connection with providing services on behalf of public listed companies. The information reported on our website or any related social media platform should not be considered advice under any circumstance.

Quick Links

VIDEOS

NEWSLETTERS

CONTACT US

ABOUT US

 

Follow Us

  • Follow
  • Follow
  • Follow

Partners

© The Market Bull. Site developed by NFIC Services.

Privacy Policy | Terms of Use |  Ethics, Standard and Corrections policy

FREE DAILY STOCK MARKET NEWS

Join our mailing list to receive the latest stock market news.

You have Successfully Subscribed!